Vyome Holdings, a company co-founded by Shiladitya Sengupta, is pursuing opportunities in the US immuno-inflammatory market, leveraging its research base in India.
2 reports, 2 independent
Updated Oct 25
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Vyome Holdings, a company co-founded by Shiladitya Sengupta, is pursuing opportunities in the US immuno-inflammatory market, leveraging its research base in India.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Shiladitya Sengupta
researcher (ORCID 0000-0003-1179-6756)
Nothing else this week.
Coverage
Newest first; wire copies grouped- tickerreport.com
- Investing.comVyome to leverage US-India ties to tackle $100B immuno-inflammatory market Investing.com -- U.S.-India focused clinical-stage pharmaceutical maker Vyome Holdings (Nasdaq: HIND) rang the opening bell